5-Bromo-2-fluorophenol

5-Bromo-2-fluorophenol Property

Melting point:

60-80 °C

Boiling point:

53℃/0.2mm

Density 

1.764±0.06 g/cm3(Predicted)

refractive index 

1.5630-1.5670

storage temp. 

Sealed in dry,Room Temperature

pka

7.74±0.10(Predicted)

form 

Crystalline

color 

Off-white

InChIKey

YPTHSYKJDRMAJY-UHFFFAOYSA-N

CAS DataBase Reference

112204-58-7(CAS DataBase Reference)

Safety

Hazard Codes 

Xi

HazardClass 

IRRITANT

HS Code 

29089990

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

P405Store locked up.

P501Dispose of contents/container to..…

5-Bromo-2-fluorophenol Chemical Properties,Usage,Production

Chemical Properties

Colorless to light yellow liquid

Uses

5-Bromo-2-fluorophenol has been used as a reactant in the preparation of 1-aryl-1-(3-arylpropyl and -propenyl)cyclopropane derivatives as insecticides.

Synthesis

General procedure for the synthesis of 5-bromo-2-fluorophenol from 5-bromo-2-fluorophenylboronic acid: a tetrahydrofuran (400 mL) solution of 2,2,6,6-tetramethylpiperidine (28 mL, 165 mmol) cooled to -20 °C was treated with n-butyllithium (63 mL of a 2.5 M hexane solution, 157.5 mmol). The mixture was cooled to -78 °C, then 1-bromo-4-fluorobenzene (16.5 mL, 150 mmol) was slowly added dropwise over 10 min and stirring was continued for 3 h at -78 °C. Triisopropyl borate (40 mL, 172.5 mmol) was then added and stirring was continued at -78 °C for 30 min. The cooling bath was removed and when the internal temperature of the reaction rose to -4 °C, 5 N hydrochloric acid (75 mL) was added and the mixture was stirred to ambient temperature. After stirring for 1 h at ambient temperature, most of the tetrahydrofuran was evaporated and the mixture was partitioned between ether (500 mL) and 1 N hydrochloric acid (500 mL). The organic phase was extracted with 2 N sodium hydroxide (400 mL) and the organic phase was discarded. The aqueous phase was cooled in an ice water bath and 5 N hydrochloric acid (150 mL) was added dropwise over 15 min. The resulting white solid was collected and dried under vacuum to give 5-bromo-2-fluorophenylboronic acid (25 g, 76%). A tetrahydrofuran solution of 5-bromo-2-fluorophenylboronic acid (25 g, 114 mmol) was treated with 35 wt% aqueous hydrogen peroxide (7.8 mL) and 4 N aqueous sodium hydroxide (1.4 mL). A mild exothermic reaction raised the internal temperature to 40 °C. The mixture was stirred at ambient temperature for 14 h. Manganese dioxide (200 mg) was then added and stirring was continued for 90 min. The reaction mixture was filtered through GF/filter paper and the filtrate was concentrated on a rotary evaporator. The residue was partitioned between ether (400 mL) and water and the organic phase was washed with water and brine and dried with anhydrous magnesium sulfate. Filtration and evaporation to dryness afforded 5-bromo-2-fluorophenol (19.7 g, 90%) as a colorless liquid. A tetrahydrofuran (50 mL) solution of ice-cooled 5-bromo-2-fluorophenol (1.91 g, 10 mmol) and L-methyl-1H-1 ,2,3-triazol-4-ylmethanol (1.24 g, 11 mmol) was treated with diisopropyl azodicarboxylate (3.03 g, 15 mmol) and triphenylphosphine (3.93 g, 15 mmol) over a period of 10 minutes. The mixture was stirred at ambient temperature for 12 h, then glacial acetic acid (1 mL) was added. The reaction mixture was concentrated under vacuum and the residue was partitioned between ethyl acetate and 0.01 N sodium hydroxide solution. The organic phase was washed with water and brine, dried with anhydrous magnesium sulfate and concentrated to give an oil. Purification was by silica gel chromatography, using a gradient of ethyl acetate (20-50%) eluting with isohexane. The product-containing fraction was concentrated and the residue was ground in isohexane with 10% ether to give 4-(5-bromo-2-fluorophenoxymethyl)-1-methyl-1H-1,2,3-triazole (1.9 g, 66%) as a white solid. Reaction of 2-(8-fluoroimidazo[1,2-a]pyridin-7-yl)propan-2-ol with 4-(5-bromo-2-fluorophenoxymethyl)-1-methyl-1H-1,2,3-triazole afforded 2-{8-fluoro-3-[4-fluoro-3-(1-methyl-1H-1,2,3-triazol-4-ylmethoxy)phenyl]imidazo[1,2-a]pyridin-7-yl} propan-2 -alcohol, as off-white solid.

References

[1] Patent: WO2003/99816, 2003, A1. Location in patent: Page 72
[2] Patent: WO2004/41826, 2004, A1. Location in patent: Page 35-36
[3] Tetrahedron, 2005, vol. 61, # 27, p. 6590 - 6595
[4] Patent: WO2006/76246, 2006, A2. Location in patent: Page/Page column 86-87
[5] Patent: US5068403, 1991, A